The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Researchers use virus to fight bacterial infection clearing way for life-saving lung transplant
Infectious Disease & AMR

Researchers use virus to fight bacterial infection clearing way for life-saving lung transplant

MAY 17, 2022
A refined microbiome “fingerprint” method tracks sub-strain variants of a single gut microbe strain
Pharma & Human Health

A refined microbiome “fingerprint” method tracks sub-strain variants of a single gut microbe strain

MAY 9, 2022
Study finds how Acinetobacter baumannii survives without water on hospital surfaces
Infectious Disease & AMR

Study finds how Acinetobacter baumannii survives without water on hospital surfaces

MAY 5, 2022
New method for probing the bewildering diversity of the microbiome
Pharma & Human Health

New method for probing the bewildering diversity of the microbiome

MAY 5, 2022
Microba Accelerates Cancer Program with New Leads
Oncology

Microba Accelerates Cancer Program with New Leads

MAY 5, 2022
Pherecydes Pharma Announces the First International Approval of a Compassionate Treatment With Its Phages
Infectious Disease & AMR

Pherecydes Pharma Announces the First International Approval of a Compassionate Treatment With Its Phages

MAY 3, 2022
Xbiome Acquires Clinical-Stage Program from Assembly Biosciences Targeting Ulcerative Colitis
Finance

Xbiome Acquires Clinical-Stage Program from Assembly Biosciences Targeting Ulcerative Colitis

APR 28, 2022
Genetics affects functions of gut microbiome
Pharma & Human Health

Genetics affects functions of gut microbiome

APR 28, 2022
Protecting the human intestinal microbiome with synthetic biology
Gastrointestinal

Protecting the human intestinal microbiome with synthetic biology

APR 18, 2022
Validation of the predictive role of A.muciniphila for response and resistance to PD1 blockade in non small cell lung cancers
Editor's Choice

Validation of the predictive role of A.muciniphila for response and resistance to PD1 blockade in non small cell lung cancers

APR 15, 2022
Did you miss Probiota Copenhagen 2022? Catch up now!
Editor's Choice

Did you miss Probiota Copenhagen 2022? Catch up now!

APR 12, 2022